The aim of the present study was to evaluate the safety , immunogenicity and persistence of the immune response after vaccination against pandemic influenza A ( H1N1pdm09 ) with an adjuvanted vaccine in human immunodeficiency virus ( HIV ) - infected adults using two single and two double doses .
